Filing Details
- Accession Number:
- 0001493152-24-010168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-15 20:00:10
- Reporting Period:
- 2024-03-13
- Accepted Time:
- 2024-03-15 20:00:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1661053 | Envveno Medical Corp | NVNO | Surgical & Medical Instruments & Apparatus (3841) | 330936180 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1964081 | Hamed Alavi | C/O Envveno Medical Corporation 70 Doppler Irvine CA 92618 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-13 | 8,334 | $3.59 | 8,334 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-13 | 8,334 | $6.22 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2024-03-13 | 8,334 | $0.00 | 8,334 | $3.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
91,666 | 2033-12-05 | No | 4 | M | Direct |
Footnotes
- The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Amended and Restated 2016 Omnibus Incentive Plan. The award is subject to time-based vesting and will vest in equal quarterly installments during the three calendar years through 2026. The portion of the stock options exercised in this transaction was fully vested and exercisable on the transaction date.